Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manish Agrawal

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Asian Journal of Endoscopic Surgery|November 27, 2024
Perioperative Outcomes and Feasibility of Single-Stage Laparoscopic Common Bile Duct Exploration (LCBDE) and Cholecystectomy With Internal Endo-Biliary Drainage for Management of Concomitant Cholelithiasis With Choledocholithiasis: A Report From a Tertiary Care HospitalAnkita Bajpai, Akshay Anand, Awanish Kumar, et al.
Journal of Psychopharmacology (Oxford, England)|August 30, 2025
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialNiall M McGowan, James J Rucker, Rachel Yehuda, et al.
The Journal of the Association of Physicians of India|July 21, 2019
Use of Ambulatory Glucose Profile for Improving Monitoring and Management of T2DMBanshi Saboo, Shruti V Sheth, Shashank Joshi, et al.
Journal of Affective Disorders|April 3, 2025
The efficacy of psychotherapeutic interventions for prolonged grief disorder: A systematic reviewTara Srivastava, Keegan Lee, Rebecca Ehrenkranz, et al.
Cancer|December 18, 2023
Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisYvan Beaussant, Elise Tarbi, Kabir Nigam, et al.
General Hospital Psychiatry|October 18, 2025
Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionYvan Beaussant, Elise Tarbi, Kabir Nigam, et al.
Cancer|December 18, 2023
Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorderManish Agrawal, William Richards, Yvan Beaussant, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2015
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumorsAmita Patnaik, Anthony Tolcher, Murali Beeram, et al.
Eclinicalmedicine|January 7, 2026
Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentNadav Liam Modlin, Victoria Williamson, Guy M Goodwin, et al.
Journal of Palliative Medicine|August 17, 2023
Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility StudyRobert Gramling, Emily Bennett, Keith Curtis, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Asian Journal of Endoscopic Surgery|November 27, 2024
Perioperative Outcomes and Feasibility of Single-Stage Laparoscopic Common Bile Duct Exploration (LCBDE) and Cholecystectomy With Internal Endo-Biliary Drainage for Management of Concomitant Cholelithiasis With Choledocholithiasis: A Report From a Tertiary Care HospitalAnkita Bajpai, Akshay Anand, Awanish Kumar, et al.
Journal of Psychopharmacology (Oxford, England)|August 30, 2025
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialNiall M McGowan, James J Rucker, Rachel Yehuda, et al.
The Journal of the Association of Physicians of India|July 21, 2019
Use of Ambulatory Glucose Profile for Improving Monitoring and Management of T2DMBanshi Saboo, Shruti V Sheth, Shashank Joshi, et al.
Journal of Affective Disorders|April 3, 2025
The efficacy of psychotherapeutic interventions for prolonged grief disorder: A systematic reviewTara Srivastava, Keegan Lee, Rebecca Ehrenkranz, et al.
Cancer|December 18, 2023
Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisYvan Beaussant, Elise Tarbi, Kabir Nigam, et al.
General Hospital Psychiatry|October 18, 2025
Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionYvan Beaussant, Elise Tarbi, Kabir Nigam, et al.
Cancer|December 18, 2023
Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorderManish Agrawal, William Richards, Yvan Beaussant, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2015
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumorsAmita Patnaik, Anthony Tolcher, Murali Beeram, et al.
Eclinicalmedicine|January 7, 2026
Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentNadav Liam Modlin, Victoria Williamson, Guy M Goodwin, et al.
Journal of Palliative Medicine|August 17, 2023
Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility StudyRobert Gramling, Emily Bennett, Keith Curtis, et al.
Pageof 9